Faeth Therapeutics, Inc. — Form 10-Q

Sensei Biotherapeutics (note: filing header says Faeth but document is Sensei) hired Brian Stephenson, PhD as Head of Operations and Finance effective March 11, 2026, at $525,000 annual base salary, up to 40% annual bonus (discretionary), and 166,435 non-qualified stock options vesting over 4 years (25% cliff after year 1, then monthly over 3 years). Severance: 9 months base + COBRA if terminated without cause outside change-of-control; 12 months base + 40% bonus lump sum + full equity acceleration if terminated without cause within 12 months of change-of-control.